Endoscopic Submucosal Dissection (ESD) is a minimally invasive procedure crucial for removing precancerous and cancerous lesions in the gastrointestinal tract
Fujifilm announced the launch of Tracmotion, the red dot award-winning Endoscopic Submucosal Dissection (ESD) device, at Endocon 2024 in Delhi. Endocon, an esteemed platform for gastroenterology advancements, witnessed the unveiling of Tracmotion alongside leading-edge procedures and discussions shaping the future of endoscopic medicine.
Endoscopic Submucosal Dissection (ESD) is a minimally invasive procedure crucial for removing precancerous and cancerous lesions in the gastrointestinal tract. It offers a targeted approach, sparing healthy tissue and enabling early intervention. Tracmotion, Fujifilm’s latest innovation, marks a paradigm shift in ESD techniques. Designed for single-operator use, its 360° rotatable retraction capability empowers precise tissue manipulation independent of the endoscope’s movement. With no locking mechanisms required, Tracmotion promises enhanced flexibility and manoeuvrability, potentially streamlining procedures. By facilitating easier, faster interventions with improved visualisation, Tracmotion holds the promise of advancing therapeutic ESD outcomes, ultimately benefiting patient care and treatment efficacy.
Dr Hathaiwan Moungthard from Thailand demonstrated Tracmotion’s efficacy in real-world clinical settings at Endocon, showcasing its potential to streamline ESD procedures and improve patient outcomes.
Dheeraj Chaudhri, Head of Endoscopy Systems Division, FUJIFILM India, shared, “The recent introduction of Tracmotion at Endocon exemplifies our relentless pursuit of innovation and excellence in endoscopic medicine. TRACMOTION revolutionises endoscopic procedures, enabling endoscopists to effortlessly control the distal end of the device with simple, single-hand movements, independent of the endoscope’s motion. By eliminating complex locking mechanisms, TRACMOTION enhances efficiency during procedures, potentially facilitating the block extraction, reducing the need for lifting agents, minimising device exchanges, and shortening procedure times.”
Tomosuke Okada, Business Advisor, Endoscopy Systems Division, FUJIFILM India, voiced, “Our dedication to pushing the boundaries of endoscopic technology reflects our commitment to enhancing patient care and supporting clinicians worldwide. By continuously innovating and refining our solutions, we aim to equip healthcare professionals with the tools they need to deliver superior diagnostics, treatments, and outcomes. Through this steadfast commitment, we strive to empower clinicians to provide the highest standard of care and positively impact the lives of patients across the globe.”
Fujifilm’s unveiling of Tracmotion, the esteemed red dot award-winning Endoscopic Submucosal Dissection (ESD) device, at Endocon 2024 in Delhi, marks a significant milestone in the realm of interventional endoscopy. As Fujifilm continues to push the boundaries of innovation in endoscopy, Tracmotion stands as a testament to its dedication to excellence and its vision of empowering clinicians to deliver superior care to patients globally.
